BRIEF-Ipsen to acquire Oncology Assets from Merrimack Pharmaceuticals

* Ipsen to acquire Oncology Assets from Merrimack Pharmaceuticals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.